ARTICLE | Company News
GW Pharma, Ipsen sales and marketing update
January 20, 2014 8:00 AM UTC
GW granted Ipsen exclusive rights to promote and distribute Sativex in Latin America, excluding Mexico and the Caribbean islands, to treat spasticity due to multiple sclerosis and cancer pain. GW will supply Sativex to Ipsen for commercialization. GW will receive an undisclosed upfront payment and is eligible for milestones, plus royalties. ...